Nunès, Jacques A. http://orcid.org/0000-0003-4865-0400
Olive, Daniel
Funding for this research was provided by:
Fondation pour la Recherche Médicale (Equipe FRM DEQ20180339209)
Article History
Received: 1 December 2021
Accepted: 4 December 2021
First Online: 15 December 2021
Competing interests
: JAN has no competing interests. DO is a cofounder and shareholder of Imcheck Therapeutics, Alderaan Biotechnology and Emergence Therapeutics and receives research funds from Imcheck Therapeutics, Alderaan Biotechnology, Cellectis and Emergence Therapeutics. All of these are outside of the submitted work.